In a significant boost to India’s biopharmaceutical innovation landscape, Alkem Laboratories Ltd. has partnered with the Indian Institute of Technology (IIT) Bombay to establish a cutting-edge Immuno-Therapeutics and Research Centre. The collaboration aims to accelerate advancements in immunology, focusing on the development of next-generation therapies for autoimmune diseases, cancer, and infectious disorders.